Synergy Pharmaceuticals Inc.’s (SGYP) MACD indicator has moved into bearish territory with a reading of –0.2917. The Zacks Rank #4 (“Sell”) stock decreased more than 0.59% to $5.02 in morning trade. The Zacks Consensus Estimate on the company’s loss for the year ending December 2013 has increased by 4 cents over the past month to a loss of 67 cents per share.
SYNERGY PHARMAC (SGYP): Free Stock Analysis Report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment